(Q35708416)

9 August 2017

title

Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease (English)

1 reference

9 August 2017

1 reference

Edan G

1

1 reference

9 August 2017

Massart C

2

1 reference

9 August 2017

Hody B

3

1 reference

9 August 2017

Poirier JY

4

1 reference

9 August 2017

Lé Reun M

5

1 reference

9 August 2017

Hespel JP

6

1 reference

9 August 2017

Leclech G

7

1 reference

9 August 2017

Simon M

8

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 February 1989

1 reference

9 August 2017

1 reference

9 August 2017

volume

298

1 reference

9 August 2017

issue

6670

1 reference

9 August 2017

page(s)

359-361

1 reference

Comparison of Effects of High and Low Dosage Regimens of Antithyroid Drugs in the Management of Graves’ Hyperthyroidism*

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1835719

Correlation between Thyrotropin-Displacing Activity and Human Thyroid-Stimulating Activity by Immunoglobulins from Patients with Graves' Disease and Other Thyroid Disorders*

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1835719

Long-term Antithyroid Treatment in Hyperthyroidism

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1835719

Short-Term Antithyroid Drug Therapy for the Thyrotoxicosis of Graves's Disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1835719

Sequelae of concussion caused by minor head injuries

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1835719

Cellular and humoral immunity in patients with hyperthyroid Graves' disease before, during and after antithyroid drug treatment

27 July 2018

1 reference

12 December 2020

Thyroid function after surgical treatment of thyrotoxicosis. A report of 100 cases treated with propranolol before operation

1 reference

12 December 2020

Relapse after Short-Term Antithyroid Therapy of Graves' Disease

1 reference

12 December 2020

Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study

1 reference

12 December 2020

Prediction of relapse in hyperthyroid Graves' disease

1 reference

12 December 2020

Human thyroid stimulating activity and clinical state in antithyroid treatment of juvenile Graves' disease

1 reference

12 December 2020

Clinical Significance of Assay of Thyroid-Stimulating Antibody in Graves' Disease

1 reference

12 December 2020

Influence of treatment with radioiodine and propylthiouracil on thyroid stimulating immunoglobulins in Graves' disease

1 reference

12 December 2020

Prognostic value of thyrotrophin binding inhibiting immunoglobulins (TBII) in longterm antithyroid treatment, 131I therapy given in combination with carbimazole and in euthyroid ophthalmopathy

1 reference

12 December 2020

The prediction of relapse after drug treatment of Graves' disease by assay of long acting thyroid stimulator-protector (LATS-P)

1 reference

12 December 2020

Early remission in thyrotoxicosis produced by short courses of treatment

1 reference

12 December 2020

Detection of thyrostimulating immunoglobulins in whole serum. Value of the culture of human thyroid cells

1 reference

12 December 2020

Thyroid function and immunological activity during and after medical treatment of Graves' disease

1 reference

12 December 2020

Clinical Experience with a Human Thyroid Cell Bioassary for Thyroid-Stimulating Immunoglobin *

1 reference

12 December 2020

Long-Term Follow-up Study of Compensated Low-Dose131I Therapy for Graves' Disease

1 reference

12 December 2020

Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease?

1 reference

12 December 2020

1 reference

12 December 2020

Assays for thyrotropin-receptor binding and thyroid-stimulating antibodies in sera from patients with Graves' disease

1 reference

12 December 2020

Do HLA-DR-typing and measurement of TSH-receptor antibodies help in the prediction of the clinical course of Graves' thyrotoxicosis after antithyroid drug treatment?

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.298.6670.359

1 reference

release_xe2ykq4cafc2zdli5a5g6if5ky

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xe2ykq4cafc2zdli5a5g6if5ky

24 November 2022

mapped directly with Wikidata item

PMC publication ID

1835719

1 reference

9 August 2017

1 reference